The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
First report of a prospective trial of proton therapy and concomittant capecitabine for patients with nonmetastatic unresectable pancreatic adenocarcinoma.
Romaine Charles Nichols
No relevant relationships to disclose
Christopher G. Morris
No relevant relationships to disclose
Thomas J. George
No relevant relationships to disclose
Robert Anthony Zaiden
No relevant relationships to disclose
Elizabeth Johnson
No relevant relationships to disclose
Bestoun H. Ahmed
No relevant relationships to disclose
Meng Wei Ho
No relevant relationships to disclose
Soon N. Huh
No relevant relationships to disclose
Nancy Price Mendenhall
No relevant relationships to disclose
Bradford S. Hoppe
No relevant relationships to disclose